Found 81 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 1/2
Interventional
This study investigates the use of an investigational medication in combination with other novel agents in participants with relapsed or refractory multiple myeloma (RRMM). The study includes several substudies with different combinations of treatments, some with and some without the drug dexamethasone.Participants in this study will undergo various procedures depending …
18 years or above
All genders
Phase 4
Interventional
This study investigates the effects of an investigational medication on preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Participants in this study will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving standard care therapy.Participants …
18 years - 90 years
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication for adults with chronic pruritus of unknown origin (CPUO). Participants in this study will be randomly assigned to one of two study arms, receiving either the investigational medication or a placebo, in addition to their usual treatment with a …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates an investigational medication for adults with moderate to severe ulcerative colitis (UC). The purpose of this study is to evaluate the effectiveness and safety of the investigational medication compared to a placebo. Participants will be divided into four study arms, with three different doses of the investigational …
12 years or above
All genders
Phase 2
Interventional
This study investigates the safety and efficacy of an investigational medication for individuals aged 12 and older with moderate to severe atopic dermatitis. The study aims to understand how this medication affects participants over a long-term period.Participants will receive the investigational medication through injections under the skin. This open-label study …
12 years or above
All genders
Phase 3
Interventional
This study investigates the efficacy and safety of an investigational medication for moderate-to-severe atopic dermatitis (AD) in participants aged 12 years and older. The study involves participants who have not responded adequately to previous biologic therapies or oral JAK inhibitors, and they will continue using topical corticosteroids (TCS) during the …
18 years or above
All genders
Phase 2
Interventional
This study investigates the long-term safety and effects of an investigational medication in adults with asthma. The purpose of this study is to evaluate how safe and effective the investigational medication is for adults who have completed previous related studies.Participants in the study will continue their treatment with the investigational …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and efficacy of an investigational medication injected under the skin in adult participants with relapsed or refractory multiple myeloma. This study aims to determine the best dose of the investigational medication for future research.Participants will be involved in two parts of the study. In Part …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the ability of participants to appropriately select and use an investigational medication for erectile dysfunction using specific labeling and a health survey assessment (HSA). The study will enroll men interested in an over-the-counter treatment for this condition.Participants will enter the study through an open-label process, meaning both …
12 years or above
All genders
Phase 4
Interventional
This study investigates the effects of an investigational medication given once a week to people with Hemophilia A who have joint swelling known as synovial hypertrophy. Participants in this study will receive the investigational medication once a week for about 12 months. During the study, doctors will monitor the participants' …